Back to news

Wolf Popper LLP Announces Investigation on Behalf of BillionToOne, Inc. Investors

Globe Newswire•19/11/2026•15:42 ET
2

Key Highlights

  • ➤BillionToOne (BLLN) fell $5.96 to $91.54 after short-seller allegations
  • ➤Fuzzy Panda Research alleged undisclosed Tennessee Medicaid-fraud investigation
  • ➤Report alleged unnecessary pregnancy-test billing and deductible reductions
  • ➤Report alleged doctor overpayments and free phlebotomists for unrelated work

NEW YORK, Nov. 19, 2026 (GLOBE NEWSWIRE) -- Wolf Popper LLP is investigating potential claims on behalf of purchasers of BillionToOne, Inc. (BillionToONe) common stock (NASDAQ: BLLN).

BillionToOne provides genetic testing and recently held its initial public offering on November 5 2025 at $60.00 per share.

Get started

Create a free account to read the full story.

Sign Up

Already have an account? Log in